When a cancer cell sloughs off the edge of a tumor in the breast, it faces a tough road to survive. The cell must not only remain physically intact as it rushes through blood vessels, but it also must find a new organ to ...
Aug 29, 2013
0
0
New research shows that the addition of the oral anti-cancer agent vorinostat to standard therapy given before, during, and after hematopoietic stem cell transplantation (HSCT) may safely reduce the incidence and severity ...
Dec 9, 2012
0
0
The cells of a rare, deadly cancer are resistant to immunotherapy. Now researchers may have found the cause, paving the way for a new type of treatment.
Jun 20, 2024
0
15
National University of Singapore researchers discovered that mechanical cues from the porous microenvironment of the bone matrix could affect the proliferation of cancer cells.
Sep 20, 2017
0
0
A Phase 2 trial led by City of Hope, a world-renowned research and treatment center for cancer and diabetes, suggests that adding the novel ataxia telangiectasia and Rad3-related (ATR) inhibitor drug berzosertib to standard-of-care ...
Aug 26, 2021
0
48
Researchers from John Theurer Cancer Center at Hackensack University Medical Center, one of the nation's 50 best cancer centers, played an important role in a study published in the New England Journal of Medicine on October ...
Nov 20, 2012
0
0
Scientists and clinicians at UCL and Great Ormond Street Hospital (GOSH) studying the effectiveness of CAR T-cell therapies in children with leukemia, have discovered a small sub-set of T-cells that are likely to play a key ...
May 24, 2021
0
13
St. Jude Children's Research Hospital investigators have identified a new form of an immune cell that protected mice from life-threatening lung infections under conditions that mimic cancer chemotherapy. The research appears ...
Sep 26, 2016
0
27
Treatment with denosumab, a drug targeted against a protein that helps promote bone destruction, decreased the number of tumor giant cells in patients with giant-cell tumor of the bone, and increased new bone formation, according ...
Sep 21, 2012
0
0
University of Iowa team discovers new biological pathway in blood vessel cells, which may contribute to the blood pressure-lowering effects of TZD drugs used to treat Type 2 diabetes. This finding may help to develop new ...
Oct 9, 2012
0
0
